Outcomes of anal cancer treated with definitive IMRT-based chemoradiation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Johnson L, Madeleine M, Newcomer L, Schwartz S, Daling J (2004) Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000. Cancer 101(2):281–288
Palefsky J (1994) Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 8(3):283
Nyitray AG, Carvalho da Silva RJ, Baggio ML, Smith D, Abrahamsen M, Papenfuss M, Lin HY, Quiterio M, Salmeron J, Lazcano-Ponce E, Villa LL, Giuliano AR (2011) Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis. doi: 10.1093/infdis/jir637
Anonymous (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 348(9034):1049–1054
Nigro N, Seydel H, Considine B, Vaitkevicius V, Leichman L, Kinzie J (1983) Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 51(10):1826–1829
Nigro N, Vaitkevicius V, Considine B (1993) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 36(7):709–711
Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset J, Gonzalez D, Peiffert D, Van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15(5):2040
Nigro N (1984) An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum 27(12):763–766
Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett C (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299(16):1914–1921. doi: 10.1001/jama.299.16.1914
Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14(9):2527–2539
John M, Pajak T, Flam M, Hoffman J, Markoe A, Wolkov H, Paris K (1996) Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am 2(4):205–211
Grills IS, Yan D, Martinez AA, Vicini FA, Wong JW, Kestin LL (2003) Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 57(3):875–890
Zelefsky MJ, Fuks Z, Happersett L, Lee HJ, Ling CC, Burman CM, Hunt M, Wolfe T, Venkatraman E, Jackson A (2000) Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55(3):241–249
Landry JC, Yang GY, Ting JY, Staley CA, Torres W, Esiashvili N, Davis LW (2002) Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity. Med Dosim 27(2):121–129
Chen YJ, Liu A, Tsai PT, Vora NL, Pezner RD, Schultheiss TE, Wong JY (2005) Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes. Int J Radiat Oncol Biol Phys 63(1):274–281. doi: 10.1016/j.ijrobp.2005.05.052
Kachnic LA, Tsai HK, Coen JJ, Blaszkowsky LS, Hartshorn K, Kwak EL, Willins JD, Ryan DP, Hong TS (2010) Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2010.09.030
Pepek JM, Willett CG, Wu QJ, Yoo S, Clough RW, Czito BG (2010) Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. Int J Radiat Oncol Biol Phys 78(5):1413–1419. doi: 10.1016/j.ijrobp.2009.09.046
Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ (2007) Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 25(29):4581–4586. doi: 10.1200/JCO.2007.12.0170
Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ (2005) Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 63(2):354–361. doi: 10.1016/j.ijrobp.2005.02.030
AJCC (2002) AJCC cancer staging manual, 6th edn. Springer, New York
Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, Das P, Gunderson LL, Hong TS, Kim JJ, Willett CG, Kachnic LA (2009) Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 74(3):824–830. doi: 10.1016/j.ijrobp.2008.08.070
National Comprehensive Cancer Network (2011) National Comprehensive Cancer Network clinical practice guidelines. http://www.nccn.org/professionals/physician_gls/pdf/anal.pdf
National Cancer Institute (2010) National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm
Eisbruch A (2009) Radiotherapy: IMRT reduces xerostomia and potentially improves QoL. Nat Rev Clin Oncol 6(10):567–568. doi: 10.1038/nrclinonc.2009.143
Fenoglietto P, Laliberte B, Allaw A, Ailleres N, Idri K, Hay MH, Moscardo CL, Gourgou S, Dubois JB, Azria D (2008) Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk. Radiother Oncol 88(1):77–87. doi: 10.1016/j.radonc.2007.12.011
Bazan JG, Hara W, Hsu A, Kunz PA, Ford J, Fisher GA, Welton ML, Shelton A, Kapp DS, Koong AC, Goodman KA, Chang DT (2011) Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer. doi: 10.1002/cncr.25901
Kachnic LA, Winter KA, Myerson R, Goodyear MD, Willins JD, Esthappan J, Haddock MG, Rotman M, Parikh PJ, Willett C (2011) Two-year outcomes of RTOG 0529: a phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. J Clin Oncol 29:suppl 4, abstr 368
Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LK (2008) Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 51(2):147–153. doi: 10.1007/s10350-007-9125-z
Ben-Josef E, Moughan J, Ajani JA, Flam M, Gunderson L, Pollock J, Myerson R, Anne R, Rosenthal SA, Willett C (2010) Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11. J Clin Oncol 28(34):5061–5066. doi: 10.1200/JCO.2010.29.1351